This fixed-dose combination pairs Glimepiride, a sulfonylurea insulin secretagogue, with sustained-release Metformin Hydrochloride, a biguanide, to support comprehensive glycemic management in type 2 diabetes mellitus.

Each unit of this sulfonylurea-biguanide combination tablet contains Glimepiride IP 1 mg + Metformin Hydrochloride IP 500 mg (sustained release), formulated in tablets form and manufactured in compliance with Indian Pharmacopoeia (IP) standards. This ensures uniform potency and quality across every production batch, a key requirement for pharmaceutical importers and distributors evaluating type 2 diabetes combination therapy medication for their regional markets.

Intended for the management of type 2 diabetes mellitus where combination therapy is clinically indicated. For distribution to pharmacies, hospitals, and diabetes care centers under medical supervision.

Supplied in 10x10 blister strips, offering a stable and export-friendly packaging format. The 10x10 Tablets configuration is widely used in international pharmaceutical trade, supporting efficient inventory management for wholesalers and institutional buyers sourcing fixed-dose antidiabetic tablet in bulk quantities.

CD&M Remedies is an established manufacturer of IP-compliant pharmaceutical formulations, supplying sulfonylurea-biguanide combination tablet to B2B buyers and importers worldwide. Buyers benefit from consistent formulation quality, reliable supply capability, and export-oriented packing suited to cross-border pharmaceutical trade.

Q: What is the composition of Glimepiride And Metformin Hydrochloride Sustained Release Tablets Cdpride-M1?
A: It contains Glimepiride IP 1 mg + Metformin Hydrochloride IP 500 mg (sustained release), manufactured to Indian Pharmacopoeia (IP) standards in tablets form.

Q: What pack sizes are available for Glimepiride And Metformin Hydrochloride Sustained Release Tablets Cdpride-M1?
A: This product is supplied in 10x10 Tablets export packing, suitable for wholesale and institutional bulk orders.

Q: Who manufactures Glimepiride And Metformin Hydrochloride Sustained Release Tablets Cdpride-M1?
A: Glimepiride And Metformin Hydrochloride Sustained Release Tablets Cdpride-M1 is manufactured and supplied by CD&M Remedies, under product code 1004.

Q: Which product category does Glimepiride And Metformin Hydrochloride Sustained Release Tablets Cdpride-M1 belong to?
A: It falls under the Anti-Diabetic Combination Medication category, intended for B2B pharmaceutical buyers and importers.